Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Athersys
Biotech
Athersys files for bankruptcy, sells assets to Healios
Athersys' last-ditch attempt to salvage the company in the wake of an unsatisfactory trial of its ischemic stroke cell therapy has been unsuccessful.
James Waldron
Jan 9, 2024 10:38am
Athersys nears bankruptcy as cell therapy fails interim analysis
Oct 10, 2023 10:50am
Athersys loses funding deal as layoffs allow backer to turn tail
Jul 8, 2022 8:41am
Prettying itself up for partners, Athersys lays off 70% of staff
Jun 3, 2022 8:47am
Athersys stock plunges 60% after stroke stem cell therapy miss
May 20, 2022 10:26am